DRD. V. Rudyk

D. V. Rudyk

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


D. V. Rudyk has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Mutually aggravating complications in the development of hepatorenal syndrome in decompensated portal hypertension

    by M.I. Tutchenko, D.M. Patrakh, D.V. Rudyk, M.S. Besedinskyi, A.V. Lovin, I.V. Klyuzko

    Background. Hepatorenal syndrome (HRS) developing in the setting of decompensated portal hypertension (PH) is characterized by progressive renal failure, elevated serum creatinine levels, and worsening oliguria. HRS occurs in approximately one-third of patients with Child-Pugh class C liver cirrhosis. The purpose was to optimize early diagnosis and treatment, as well as to identify risk factors for the development of HRS and associated mortality. Materials and methods. A total of 126 medical records of patients with decompensated PH treated at the Kyiv City Emergency Hospital and the Department of Surgery, Dental Faculty, Bogomolets National Medical University, between 2022 and 2024 were analyzed. HRS was diagnosed in 51 (40.5 %) cases. Diagnostic criteria included an increase in serum creatinine > 150 µmol/L (1.69 mg/dL) or ≥ 26.5 µmol/L (0.3 mg/dL) within 48 hours in the presence of oliguria and absence of other signs of intrinsic renal injury, particularly hematuria. Patients were divided into two groups. The first group included 24 (47.1 %) patients in whom HRS and community-acquired spontaneous bacterial peritonitis (SBP) were diagnosed within the first 24 hours, and a restrictive transfusion strategy was applied. The second group comprised 27 (52.9 %) participants in whom HRS and nosocomial SBP were diagnosed on days 3–5 of hospitalization, and a liberal transfusion strategy was used. The impact of transfusion strategy, ascites severity, and SBP as mutually aggravating factors in HRS development was assessed. Results. Analysis showed that the combination of large-volume ascites, SBP, and a liberal transfusion strategy forms an unfavorable prognostic complex associated with a significantly increased risk of mortality. HRS development was more frequently associated with large-volume ascites (70.8 %), nosocomial SBP (37.0 %), and a liberal transfusion strategy (52.9 %). Among 126 patients, 27 (21.4 %) underwent surgery. In the postoperative period, HRS developed in 1 (4.2 %) patient in the first group and in 2 (7.4 %) patients in the second group. Overall mortality was 74.5 % (n = 38), with 14 deaths (58.3 %) in the first group and 24 (88.9 %) in the second group (p = 0.03). According to ROC analysis, the model demonstrated high predictive performance for mortality (AUC = 0.909; 95% CI 0.831–0.987), confirming strong discriminative ability for risk stratification in patients with HRS. Conclusions. HRS is a severe complication of decompensated PH associated with high mortality. A liberal transfusion strategy, severe ascites, and SBP increase the risk of its development and progression. Early monitoring of urine output and serum creatinine levels is critical for timely diagnosis, prevention, and management of HRS.

  • Open Access

    The role of CT visualization of the visceral basin in choosing treatment strategy in patients with variceal bleeding associated with portal hypertension

    by D.V. Rudyk, M.I. Tutchenko, A.V. Lovin, D.M. Patrakh, O.O. Dyrda, M.S. Besedinskyi

    Background. The development of portal hypertension with the opening of collateral vessels is a characteristic sign of portal hemodynamic disorders, which often leads to such a threatening condition as bleeding from esophageal/gastric varices, which is accompanied by high mortality. The vast majority of cases of portal hypertension are associated with cirrhosis, while less common etiological factors are caused by portosinusoidal vascular disease and chronic portal vein thrombosis. The opening of multiple spontaneous portosystemic shunts (SPSS) in response to increased blood volume is a characteristic sign of increased portal pressure, impaired portal hemodynamics, and is a compensatory mechanism aimed at decompression. Purpose – using contrast-enhanced CT and 3D remodelling, assess the prevalence and individual anatomical features of clinically significant and ʼdangerousʼ collateral venous vessels in terms of variceal bleeding and to determine the impact of CT examination on the selection of optimal individualised treatment tactics for patients with variceal bleeding against the background of portal hypertension. Materials and methods. The results of CT studies of 79 patients who were admitted with bleeding from esophageal/gastric varicose veins on the background of portal hypertension and were inpatients from 2019 to 2025 at the Kyiv City Clinical Hospital of Emergency Medicine, which is the clinical base of the Department of Surgery of the Institute of Dentistry of the Bogomolets National Medical University, were analyzed. Results. Analyzing the results of contrast-enhanced CT scans and 3D visualization of the visceral basin, it was found that among all types of SPSS in patients admitted with variceal bleeding, the most common were: gastroesophageal, observed in 68 (87.1%) patients, dilated coronary veins were detected in 72 (91.1%), paraeso- phageal veins – 15 (18.9%), spontaneous splenorenal shunt – 18 (22.7%), gastro- renal shunt – 3 (3.8%), paraumbilical vein recanalization – 19 (24.0%), veins of Retzius (retroperitoneal venous plexus) – 9 (11.4%), cardiophrenic tract – 7 (8.9%), inferior mesenteric collateral vessels – 11 (13.9%), rectal venous plexus – 1 (1.3%). It should also be noted that in 13 (22%) the size of the «dominant» shunts exceeded 1 cm in diameter. Conclusion. Anatomical variability, degree of dilation, and numerous combinations of portosystemic shunts create unique hemodynamic conditions in each patient, which may have a specific impact on the clinical manifestations, prognosis, and survival of the patient. The use of CT scan in clinical practice can be considered the gold standard for accurate diagnosis of PG, detection of SPSS, which plays a key role in determining the drainage pathways of portal blood, anatomical and individual features of the patientʼs visceral vascular basin. Determining the optimal management, including surgical treatment of variceal bleeding, depends on identifying individual characteristics of the visceral vascular basin and collateral pathways of portal blood drainage and depends on the rational use of imaging instrumental examination methods such as CT with vascular enhancement and 3D reconstruction of visceral vessels.

  • Open Access

    GASTROINTESTINAL BLEEDING AGAINST THE BACKGROUND OF NON-CIRRHOTIC PORTAL HYPERTENSION IN A PATIENT WITH MYELOFIBROSIS (CASE REPORT)

    by Diana Rudyk, Mykola Tutchenko, Mykola Besedinskyi, Sergey Chub, Andrii Lovin, Ihor Ahapchenko

    Portal hypertension in the absence of cirrhotic transformation of the liver parenchyma is considered a rare pathology with a difficult diagnostics. Non-cirrhotic portal hypertension includes a heterogeneous group of conditions based on porto-sinusoidal vascular disease of the liver and chronic portal vein thrombosis. For a long time, the course of the disease can remain asymptomatic and is usually manifested by the development of one of the complications of portal hypertension. One of the most dangerous and often fatal complications is bleeding from varicose veins of the esophagus and stomach. The purpose of this article is to demonstrate, using the example of a clinical case, the peculiarities of diagnosis and methods of successful treatment of bleeding from esophageal phlebectasia in case of non-cirrhotic portal hypertension caused by splenic vein thrombosis. The article describes the clinical case of a 57-year-old patient with a bleeding from esophageal varices with non-cirrhotic portal hypertension caused by splenic vein thrombosis due to myelofibrosis. The patient was urgently hospitalized with symptoms of hemorrhagic shock, which required intensive care, varix ligation and hemotransfusion therapy. After stabilization of hemodynamic parameters, the patient underwent a porto-azygos disconnection operation, which included devascularization of the distal esophagus, proximal stomach, transection of the esophagus and splenectomy. Conclusions. Myeloproliferative diseases are one of the many causes of non-cirrhotic portal hypertension, which often remain unrecognized until its decompensation. The diagnosis of non-cirrhotic portal hypertension is often difficult, which directly affects the prognosis. The authors' goal was to draw attention, raise awareness, and demonstrate the pathogenetic link between these conditions, the given clinical case of surgical treatment can be a variant of medical tactics aimed at controlling bleeding from esophageal and gastric phlebectasia. The positive feature of the performed surgical intervention is the direct impact on the source of bleeding, namely, the disconnection of the portal and caval venous systems, which ensured the cessation of blood flow through the esophageal-gastric collaterals. Taking into account the risks of anticoagulant therapy in patients with portal hypertension with Portal vein thrombosis and bleeding from varicose veins of the esophagus and stomach we recommend long-term (3–6 months) anticoagulant therapy in patients with prothrombotic conditions after porto-azygos disconnection and exclusion of “dangerous” esophageal-gastric collaterals, which makes it possible to effectively control hemorrhagic complications.

  • Open Access

    Hepatorenal syndrome in decompensated portal hypertension

    by M.I. Tutchenko, M.S. Besedinskyi, S.A. Aslanian, I.V. Kluzko, D.V. Rudyk, S.L. Chub

    Hepatorenal syndrome is the development of kidney failure in patients with decompensated chronic diseases with portal hypertension. This study aimed to search for optimal methods of early diagnostics, therapeutic approaches and establishment of lethality causes in hepatorenal syndrome. The research presents the outcomes of treatment of 192 patients diagnosed with hepatorenal syndrome and undergoing inpatient care at the Municipal non-profit enterprise “Kyiv City Clinical Emergency Hospital” and the Clinic of the Department of Surgery of the Dental Faculty of the Bogomolets National Medical University between 2018 and 2023. Renal dysfunction and increased creatinine were detected in 192 (43.9%) out of 437 patients with decompensated portal hypertension, who were subsequently divided into two groups based on the degree of decompensation. The first group, comprising 57 (29.7%) patients, fell into class B according to the Child-Pugh scale and had <30 points according to the MELD scale. The second group consisted of 135 (70.3%) patients classified as class C and ≥30 points according to the MELD scale. In the treatment of hepatorenal syndrome, as well as in order to ensure an euvolemic state and prevent circulatory dysfunction, after therapeutic paracentesis, an infusion of 20% albumin solution at the rate of 6-8 g/l of evacuated ascites was used. The appointment of terlipsin in patients with portal hypertension complicated by bleeding in the presence of hepatorenal syndrome had a double effect in the form of a constrictor effect aimed both at stopping bleeding and at changing the splanchnic blood flow, which contributes to the improvement of kidney function. Stopping bleeding, eliminating the infectious factor in ascitic fluid, reducing intra-abdominal pressure, correcting biochemical parameters, and optimizing intra-abdominal blood flow were components of the treatment of hepatorenal syndrome. Depending on the combination of the number and severity of complications of portal hypertension, the number of unsatisfactory treatment results also increased. The total mortality in the development of hepatorenal syndrome was 80.2%. The primary criterion for diagnosing hepatorenal syndrome is the control of diuresis and its daily decline, coupled with an increase in creatinine levels exceeding 30 mmol/l within 48 hours.Varicose bleeding, severe ascites accompanied by intra-abdominal hypertension, and spontaneous bacterial peritonitis serve both as triggering factors for hepatorenal syndrome development and increase mortality rates.


  • Open Access

    Recurrent variceal bleeding in alcoholic liver cirrhosis (a case report)

    by M.I. Tutchenko, D.V. Rudyk, S.A. Aslanian, S.L. Chub, M.S. Besedinskyi

    Alcoholic liver cirrhosis is widely known to doctors for its complications, including variceal bleeding from the esophagus and/or stomach. Recurrent variceal bleeding is considered a sign of decompensated portal hypertension. As fibrosis in the liver progresses, the gradient of portal pressure increases steadily, and each subsequent bleeding indicates a worsening survival prognosis. There are variety of measures available now to prevent upper gastrointestinal variceal bleeding. In the clinical case, the methods used to prevent repeated bleeding are described. Despite their use, numerous variceal bleedings were registered, which demonstrated the exceptional compensatory capabilities of the patient. In addition, long-term abstinence from the harmful factor, an alcohol, seems to be the most effective measure in this case.


  • Open Access

    Spontaneous bacterial peritonitis in patients with portal hypertension

    by M.I. Tutchenko, M.S. Besedinskyi, D.V. Rudyk, S.L. Chub, I.V. Klyuzko, G.G. Roshchin

    Background. Spontaneous bacterial peritonitis (SBP) is a life-threatening infection in patients with portal hypertension (PH) and ascites. Its prevention and treatment are vital to improve the prognosis in decompensated PH. Alterations in gut microbiota, gut permeability, and systemic immune dysfunction are cornerstones in the development of SBP in patients with PH. This contributes to the translocation of bacteria from the intestinal lumen to the mesenteric lymph nodes, and then to the portal and systemic circulation from where the ascitic fluid can be colonized with the subsequent development of peritonitis. The purpose was to monitor the course of the disease and determine the possibility of correcting pathological factors of SBP such as bacterial contamination and volume of ascitic fluid, nature of bacterial contamination, increased intra-abdominal pressure, hypoalbuminemia, and to evaluate the role of antibacterial therapy, paracentesis in the treatment of patients with SBP in decompensated PG. Materials and methods. Examination and treatment of 242 patients with ascites who were admitted for emergency medical care were carried out. Diagnostic paracentesis was performed to examine ascitic fluid, which allowed to detect neutrophilia > 250 cells in 1 mm3 in 194 (80.2 %) patients and indicated the presence of SBP. These patients made up the first group of observation. In the second group, there were 48 (19.8 %) patients with no clinical and laboratory signs of SBP at the time of hospitalization. Methodology of analysis of actual research material: to find a statistical difference between the distribution of nominal data of patients in this study, we used Pearson’s χ2 test. To establish the strength of the relationship between variables, we determined the polychoric correlation coefficient. When a statistically significant difference was detec-ted, a stratification analysis was performed with determination of the 95% confidence interval of the odds ratio (Clopper-Pearson method) and the risk ratio for the development of complications in PH. Results. Empiric antibacterial therapy, which was carried out from the moment of receiving information about SBP and began with the use of broad-spectrum antibiotics, was successful in 41 % of cases that was confirmed by repeated examination of ascitic fluid. In antibiotic resistance, determining the sensitivity of ascitic microflora led to a delay in an effective anti-inflammatory treatment and affected the results. In the first group, 39 (20.1 %) patients died, in the second group, 22 (50 %), total mortality was 25.2 %. Conclusions. Diagnostic paracentesis combined with the assessment of bacterial contamination of ascitic fluid, evaluation of intra-abdominal pressure, state of osmoregulation based on albumin concentration is a safe and informative method of diagnosing the severity of pathological process in patients with complicated PH. Treatment of SBP requires urgent care, both in terms of elimination of the infectious factor, and normalization of the disturbed mechanisms of reabsorption regulation by peritoneal and hepatorenal processes. High mortality in patients with SBP is due to the development of inflammation in the abdominal cavity against the background of progressive hepatorenal insufficiency and the inability to correct decompensated PH.


  • Open Access

    Features of the course of hepatorenal syndrome in decompensated portal hypertension (case report)

    by M.I. Tutchenko, D.V. Rudyk, M.S. Besedinskyi, S.L. Chub, Yu.V. Nerushchenko

    Hepatorenal syndrome is a critical and potentially life-threatening complication in patients with advanced liver cirrhosis, characterized by the development of renal dysfunction in the absence of underlying structural kidney disease. Despite some encouraging studies of pharmacological treatments, the development of hepatorenal syndrome in people with cirrhosis implies a poor prognosis, as renal failure is usually irreversible unless a liver transplantation is performed. The purpose is to show the peculiarities of hepatorenal syndrome and the method of its successful treatment. The article describes a clinical case of hepatorenal syndrome in the postoperative period in a 54-year-old woman who was hospitalized urgently with bleeding esophageal varices. She has a history of liver cirrhosis associated with HCV and portal vein thrombosis, portal hypertension syndrome, blee­ding esophageal varices, ascites. After stabilization of hemodynamic parameters, the patient underwent a portoazygous disconnection, which included devascularization of the distal esophagus, proximal stomach, and esophageal transection. The first day of the postoperative period was complicated by the development of hepatorenal syndrome. Only its timely diagnosis in decompensated portal hypertension, with the elimination of pathophysiological components of the pathological process, allows correcting this complex pathology. When draining ascites, detoxification of the body is possible, which makes it possible to partially compensate for impaired kidney function. Albumin replacement therapy helps maintain osmotic balance.


  • Open Access

    Treatment of portal hypertension complicated by variceal bleeding

    by M.I. Tutchenko, D.V. Rudyk, І.V. Klyuzko, M.S. Besedinskyi, S.L. Chub, О.а. Sirenko

    Background. Mortality in variceal bleeding (VB) on the background of portal hypertension (PH) is highest among patients with gastrointestinal bleeding. The treatment of PH complicated by VB is a complex problem that is far from being solved, especially in case of Child-Pugh class B and C decompensation. The aim of the study was to determine the causes of PH complicated by VB, features of conservative and interventional therapy, indications and nature of surgical procedures, treatment efficacy, as well as causes of complications and mortality. Materials and methods. We analyzed treatment outcomes of 923 inpatients with PH complicated by VB who were treated in the clinic of the Department of Surgery of the Faculty of Dentistry of Bogomolets National Medical University on the basis of the Kyiv City Clinical Emergency Hospital from 2012 to 2023. It was possible to talk about the cause of PH based on anamnestic data in 61 % of cases. In 711 (77 %) patients, the source of bleeding was detected endoscopically within 30–60 minutes from the moment of admission to the clinic. Conservative therapy included the administration of hemostatic and agents lowering pressure in the portal system, as well as vasoconstrictors that reduce portal blood flow. For the failure of conservative therapy, unstable hemostasis, and repeated previous bleedings, 59 (6.4 %) patients were operated. The methodology of the research analysis consisted in the fact that the arithmetic mean and standard error (M ± m) were determined as the characteristics of the groups for features with a distribution corresponding to the Gaussian law. This reference method of descriptive statistics was applied to evaluate surgical treatment in comparison with conservative therapy and interventional measures. Results. Endoscopic hemostasis by the ligature method was achieved in 97 (10.5 %) patients. Repeated endoscopy due to VB recurrence was done in 276 (29.9 %) participants. In cases of unsatisfactory endoscopic hemostasis, as well as recurrent VB, a Sengstaken-Blakemore probe was installed. In case of right-sided PH, the formation of varices in the esophagus is caused by the discharge of blood mainly through the coronary vein, which required its transection during еsophagogastric devascularization. In compliance with this rule, the patients underwent esophagogastric devascularization, circular transection of the esophagus, which provided portoazygous disconnection. The total mortality rate was 43.1 %, among operated people — 8.5 %, and among non-operated ones — 42.1 %. Conclusions. PH complicated by VB is evidence of decompensated processes in the liver parenchyma or obstruction in the portal system. Conservative therapy and interventional measures make it possible to stop bleeding and prepare the patient for elective surgery, if necessary. An operation that stops blood flow through dilated veins of the esophagus or stomach is an effective method of treating bleeding in portal hypertension.


  • Open Access

    Decompensated portal hypertension complicated by bleeding

    by M.I. Tutchenko, D.V. Rudyk, M.S. Besedinskyi

    Despite the fact that the risk of death from esophagogastric variceal bleeding caused by portal hypertension is highest in patients with gastrointestinal bleeding, the diagnosis and treatment need to be further improved. This study is based on the analysis of scientific and practical data about the diagnosis and treatment of patients with complicated portal hypertension, which allows us to understand the complexity of the pathological process, the causes of unsatisfactory diagnostic and treatment results, and the possibility of providing routine and emergency care. Management of portal hypertension includes prevention of the first bleeding, treatment of acute variceal bleeding, and prevention of recurrent bleeding. The literature review based on sources from PubMed, MEDLINE aims to demonstrate the methods of diagnosing and treating bleeding from the esophageal and gastric veins in medical institutions with different levels of capacity.


  • SPONTANEOUS BACTERIAL PERITONITIS

    by Mykola Tutchenko, Diana Rudyk, Mykola Besedinskyi, Sergey Chub

    Spontaneous bacterial peritonitis (SBP) is an infection of ascitic fluid, posing a severe complication in patients with portal hypertension (PH). Hospital mortality rates are exceedingly high, sometimes surpassing 85%. Only timely diagnosis and treatment can mitigate mortality and morbidity levels. Purpose. Through literature analysis and review, demonstrate the necessity, appropriateness, and efficacy of SBP treatment in patients with decompensated portal hypertension. Additionally, highlight the potential development of ascites and subsequent infections, which may not always be linked to liver cirrhosis. Materials and methods. This article conducts a literature review and assesses recommendations, findings from randomized controlled trials, meta-analyses, and other review articles published in databases such as PubMed, Scopus, Web of Science, and Google Scholar between 2000 and 2023. Outcome. Diagnostic paracentesis is recommended for all ascites patients requiring emergency care or hospitalization to ascertain SBP presence. Accurate differentiation between SBP and secondary bacterial peritonitis is crucial, as treatment approaches differ for each condition. Conclusions. Standard SBP treatment entails promptly administering broad-spectrum antibiotics, considering the potential for community-acquired or nosocomial SBP, and factoring in microbial antibiotic resistance. Given SBP's annual mortality rate surpassing 50%, liver transplantation is recommended for SBP survivors.